Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LYPLA1 Antikörper (Middle Region)

LYPLA1 Reaktivität: Human, Maus, Ratte, Kaninchen, Rind (Kuh), Meerschweinchen, Pferd, Hund, Saccharomyces cerevisiae, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN503315
  • Target Alle LYPLA1 Antikörper anzeigen
    LYPLA1 (Lysophospholipase I (LYPLA1))
    Bindungsspezifität
    • 17
    • 7
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region
    Reaktivität
    • 40
    • 19
    • 12
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus, Ratte, Kaninchen, Rind (Kuh), Meerschweinchen, Pferd, Hund, Saccharomyces cerevisiae, Zebrafisch (Danio rerio)
    Wirt
    • 42
    • 4
    Kaninchen
    Klonalität
    • 44
    • 2
    Polyklonal
    Konjugat
    • 26
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser LYPLA1 Antikörper ist unkonjugiert
    Applikation
    • 29
    • 20
    • 13
    • 11
    • 7
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Sequenz
    SWFDIIGLSP DSQEDESGIK QAAENIKALI DQEVKNGIPS NRIILGGFSQ
    Homologie
    Cow: 100%, Dog: 93%, Guinea Pig: 100%, Horse: 86%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Yeast: 79%, Zebrafish: 93%
    Produktmerkmale
    This is a rabbit polyclonal antibody against LYPLA1. It was validated on Western Blot using a cell lysate as a positive control.
    Aufreinigung
    Affinity Purified
    Immunogen
    The immunogen is a synthetic peptide directed towards the middle region of human LYPLA1
    Top Product
    Discover our top product LYPLA1 Primärantikörper
  • Applikationshinweise
    Optimal working dilutions should be determined experimentally by the investigator.
    Kommentare

    Antigen size: 230 AA

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
  • Target
    LYPLA1 (Lysophospholipase I (LYPLA1))
    Andere Bezeichnung
    LYPLA1 (LYPLA1 Produkte)
    Synonyme
    APT-1 antikoerper, APT1 antikoerper, LPL-I antikoerper, LPL1 antikoerper, hAPT1 antikoerper, Pla1a antikoerper, 25KDL antikoerper, zgc:110260 antikoerper, lysophospholipase I antikoerper, lysophospholipase 1 antikoerper, lysophospholipase I L homeolog antikoerper, LYPLA1 antikoerper, Lypla1 antikoerper, lypla1 antikoerper, lypla1.L antikoerper
    Hintergrund
    Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. LYPLA1 hydrolyzes lysophosphatidylcholine in both monomeric and micellar forms. The use of alternate polyadenylation sites has been found for this gene.Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene hydrolyzes lysophosphatidylcholine in both monomeric and micellar forms. The use of alternate polyadenylation sites has been found for this gene. There are alternatively spliced transcript variants described for this gene but the full length nature is not known yet.
    Alias Symbols: APT-1, LPL1, LYSOPLA, hAPT1
    Protein Interaction Partner: GOLGA2, UBC, VCAM1, ITGA4, FN1, ELAVL1, LYPLA1, ANXA2,
    Protein Size: 230
    Molekulargewicht
    25 kDa
    Gen-ID
    10434
    NCBI Accession
    NM_006330, NP_006321
    UniProt
    O75608
Sie sind hier:
Kundenservice